SES/Force4 team applies a Risk Management approach to the product development process that can reduce cost, time-to-market, and liability risk.
FDA Cranks Up Pressure for Modeling and Simulation
FDA Cranks up Pressure for Modeling and Simulation In November 2023, the FDA released new guidance on assessing the credibility of computational modeling and simulation (CM&S) in medical device submissions. This guidance underscores the agency's...